BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29116599)

  • 1. The Class-A GPCR Dopamine D2 Receptor Forms Transient Dimers Stabilized by Agonists: Detection by Single-Molecule Tracking.
    Kasai RS; Ito SV; Awane RM; Fujiwara TK; Kusumi A
    Cell Biochem Biophys; 2018 Jun; 76(1-2):29-37. PubMed ID: 29116599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Reconstitution of Dopamine D2 Receptor into a Supported Model Membrane in a Nanometric Confinement.
    Nagai R; Sugimachi A; Tanimoto Y; Suzuki KGN; Hayashi F; Weikert D; Gmeiner P; Kasai RS; Morigaki K
    Adv Biol (Weinh); 2021 Dec; 5(12):e2100636. PubMed ID: 34761565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level.
    Tabor A; Weisenburger S; Banerjee A; Purkayastha N; Kaindl JM; Hübner H; Wei L; Grömer TW; Kornhuber J; Tschammer N; Birdsall NJ; Mashanov GI; Sandoghdar V; Gmeiner P
    Sci Rep; 2016 Sep; 6():33233. PubMed ID: 27615810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization.
    Wang M; Pei L; Fletcher PJ; Kapur S; Seeman P; Liu F
    Mol Brain; 2010 Sep; 3():25. PubMed ID: 20813060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stoichiometric analysis of oligomeric states of three class-A GPCRs, chemokine-CXCR4, dopamine-D2, and prostaglandin-EP1 receptors, on living cells.
    Kawano K; Yagi T; Fukada N; Yano Y; Matsuzaki K
    J Pept Sci; 2017 Jul; 23(7-8):650-658. PubMed ID: 28626925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin B2 and dopamine D2 receptors form a functional dimer.
    Niewiarowska-Sendo A; Polit A; Piwowar M; Tworzydło M; Kozik A; Guevara-Lora I
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1855-1866. PubMed ID: 28757212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homobivalent Dopamine D
    Ullmann T; Gienger M; Budzinski J; Hellmann J; Hübner H; Gmeiner P; Weikert D
    ACS Chem Biol; 2021 Feb; 16(2):371-379. PubMed ID: 33435665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the heterotetrameric structure of the adenosine A2A-dopamine D2 receptor complex.
    Casadó-Anguera V; Bonaventura J; Moreno E; Navarro G; Cortés A; Ferré S; Casadó V
    Biochem Soc Trans; 2016 Apr; 44(2):595-600. PubMed ID: 27068975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 Co-immunoprecipitation and fluorescence resonance energy transfer analysis.
    Baragli A; Alturaihi H; Watt HL; Abdallah A; Kumar U
    Cell Signal; 2007 Nov; 19(11):2304-16. PubMed ID: 17706924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules.
    Hern JA; Baig AH; Mashanov GI; Birdsall B; Corrie JE; Lazareno S; Molloy JE; Birdsall NJ
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2693-8. PubMed ID: 20133736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Instability of a class a G protein-coupled receptor oligomer interface.
    Fonseca JM; Lambert NA
    Mol Pharmacol; 2009 Jun; 75(6):1296-9. PubMed ID: 19273553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bias analyses of preclinical and clinical D2 dopamine ligands: studies with immediate and complex signaling pathways.
    Brust TF; Hayes MP; Roman DL; Burris KD; Watts VJ
    J Pharmacol Exp Ther; 2015 Mar; 352(3):480-93. PubMed ID: 25539635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging.
    Kasai RS; Suzuki KG; Prossnitz ER; Koyama-Honda I; Nakada C; Fujiwara TK; Kusumi A
    J Cell Biol; 2011 Feb; 192(3):463-80. PubMed ID: 21300851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-dependent internalization of D2 receptors: Imaging quantification by confocal microscopy.
    Goggi JL; Sardini A; Egerton A; Strange PG; Grasby PM
    Synapse; 2007 Apr; 61(4):231-41. PubMed ID: 17230553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomerization of dopamine and serotonin receptors.
    Lee SP; Xie Z; Varghese G; Nguyen T; O'Dowd BF; George SR
    Neuropsychopharmacology; 2000 Oct; 23(4 Suppl):S32-40. PubMed ID: 11008065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homodimerization of Drosophila Class A neuropeptide GPCRs: Evidence for conservation of GPCR dimerization throughout metazoan evolution.
    Rizzo MJ; Johnson EC
    Biochem Biophys Res Commun; 2020 Mar; 523(2):322-327. PubMed ID: 31864711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent ligands for dopamine D
    Allikalt A; Purkayastha N; Flad K; Schmidt MF; Tabor A; Gmeiner P; Hübner H; Weikert D
    Sci Rep; 2020 Dec; 10(1):21842. PubMed ID: 33318558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer.
    Marcellino D; Navarro G; Sahlholm K; Nilsson J; Agnati LF; Canela EI; Lluís C; Århem P; Franco R; Fuxe K
    Biochem Biophys Res Commun; 2010 Apr; 394(4):988-92. PubMed ID: 20307491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
    Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.